-
1
-
-
0028593992
-
Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPARγ and RXRα
-
1. Tontonoz, P., Graves, R. A., Budavari, A. I., Erdjument-Bromage, H., Lui, M., Hu, E., Tempst, P., and Spiegelman, B. M. (1994) Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPARγ and RXRα. Nuc. Acids Res. 22, 5628-5634.
-
(1994)
Nuc. Acids Res.
, vol.22
, pp. 5628-5634
-
-
Tontonoz, P.1
Graves, R.A.2
Budavari, A.I.3
Erdjument-Bromage, H.4
Lui, M.5
Hu, E.6
Tempst, P.7
Spiegelman, B.M.8
-
2
-
-
0028015713
-
Peroxisome proliferator-activated receptor γ: Adipose-predominant expression and induction early in adipocyte differentiation
-
2. Chawla, A., Schwarz, E. J., Dimaculangan, D. D., and Lazar, M. A. (1994) Peroxisome proliferator-activated receptor γ: Adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135, 798-800.
-
(1994)
Endocrinology
, vol.135
, pp. 798-800
-
-
Chawla, A.1
Schwarz, E.J.2
Dimaculangan, D.D.3
Lazar, M.A.4
-
3
-
-
0028641559
-
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
-
3. Tontonoz, P., Hu, E., and Spiegelman, B. M. (1994) Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79, 1147-1156.
-
(1994)
Cell
, vol.79
, pp. 1147-1156
-
-
Tontonoz, P.1
Hu, E.2
Spiegelman, B.M.3
-
4
-
-
0028988487
-
PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene
-
4. Tontonoz, P., Hu, E., Devine, J., Beale, E. G., and Spiegelman, B. M. (1995) PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. and Cell. Biol. 15, 351-357.
-
(1995)
Mol. and Cell. Biol.
, vol.15
, pp. 351-357
-
-
Tontonoz, P.1
Hu, E.2
Devine, J.3
Beale, E.G.4
Spiegelman, B.M.5
-
7
-
-
0029016829
-
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ
-
7. Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., and Kliewer, S. A. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ. J. Biol. Chem. 270, 12953-12956.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 12953-12956
-
-
Lehmann, J.M.1
Moore, L.B.2
Smith-Oliver, T.A.3
Wilkison, W.O.4
Willson, T.M.5
Kliewer, S.A.6
-
8
-
-
0029892126
-
An antidiabetic thiazolidinedione potentiates insulin stimulation of glycogen synthase in rat adipose tissues
-
8. Berger, J., Biswas, C., Hayes, N., Ventre, J., Wu, M., and Doebber, T. W. (1996) An antidiabetic thiazolidinedione potentiates insulin stimulation of glycogen synthase in rat adipose tissues. Endocrinology 137, 1984-1990.
-
(1996)
Endocrinology
, vol.137
, pp. 1984-1990
-
-
Berger, J.1
Biswas, C.2
Hayes, N.3
Ventre, J.4
Wu, M.5
Doebber, T.W.6
-
9
-
-
0026664271
-
New oral thiazolidinedione antidiabetic agents act as insulin sensitizers
-
9. Hofmann, C. A., and Colca, J. R. (1992) New oral thiazolidinedione antidiabetic agents act as insulin sensitizers. Diabetes Care 15, 1075-1078.
-
(1992)
Diabetes Care
, vol.15
, pp. 1075-1078
-
-
Hofmann, C.A.1
Colca, J.R.2
-
10
-
-
0029102676
-
Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: Alternative promoter use and different splicing yield two mPPARγ isoforms
-
10. Zhu, Y., Qi, C., Korenberg, J. R., Chen, X-N., Noya, D., Rao, M. S., and Reddy, J. K. (1995) Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: Alternative promoter use and different splicing yield two mPPARγ isoforms. Proc. Natl. Acad. Sci. USA 92, 7921-7925.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 7921-7925
-
-
Zhu, Y.1
Qi, C.2
Korenberg, J.R.3
Chen, X.-N.4
Noya, D.5
Rao, M.S.6
Reddy, J.K.7
-
11
-
-
0030590074
-
Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors γ1 and γ2
-
11. Elbrecht, A., Chen, Y., Cullinan, C. A., Hayes, N., Leibowitz, M. D., Moller, D. E., and Berger, J. (1996) Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors γ1 and γ2. Biochem. and Biophys. Res. Commun. 224, 431-437.
-
(1996)
Biochem. and Biophys. Res. Commun.
, vol.224
, pp. 431-437
-
-
Elbrecht, A.1
Chen, Y.2
Cullinan, C.A.3
Hayes, N.4
Leibowitz, M.D.5
Moller, D.E.6
Berger, J.7
-
12
-
-
0030977450
-
Peroxisome proliferator-activated receptor gene expression in human tissues: Effects of obesity, weight loss, and regulation by insulin and glucocorticoids
-
12. Vidal-Puig, A. J., Considine, R. V., Jimenez-Liñan, M., Werman, A., Pories, W. J., Caro, J. F., and Flier, J. S. (1997) Peroxisome proliferator-activated receptor gene expression in human tissues: Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J. Clin. Invest. 99, 2416-2422.
-
(1997)
J. Clin. Invest.
, vol.99
, pp. 2416-2422
-
-
Vidal-Puig, A.J.1
Considine, R.V.2
Jimenez-Liñan, M.3
Werman, A.4
Pories, W.J.5
Caro, J.F.6
Flier, J.S.7
-
13
-
-
0030951143
-
Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists
-
13. Mukherjee, R., Jow, L., Croston, G. E., and Paterniti, J. R., Jr. (1997) Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists. J. Biol. Chem. 272, 8071-8076.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 8071-8076
-
-
Mukherjee, R.1
Jow, L.2
Croston, G.E.3
Paterniti J.R., Jr.4
-
14
-
-
0004473133
-
PPARγ gene expression is elevated in skeletal muscle of obese and type II diabetic subjects
-
14. Park, K. S., Ciaraldi, T. P., Abrams-Carter, L., Mudaliar, S., Nikoulina, S. E., and Henry, R. R. (1997) PPARγ gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes 46, 1230-1234.
-
(1997)
Diabetes
, vol.46
, pp. 1230-1234
-
-
Park, K.S.1
Ciaraldi, T.P.2
Abrams-Carter, L.3
Mudaliar, S.4
Nikoulina, S.E.5
Henry, R.R.6
-
15
-
-
0030747895
-
Tissue distribution and quantification of the expression of mrnas of peroxisome proliferator-activated receptors and liver X receptor-α in humans: No alteration in adipose tissue of obese and NIDDM patients
-
15. Auboeuf, D., Rieusset, J., Fajas, L., Vallier, P., Frering, V., Riou, J. P., Staels, B., Auwerx, J., Laville, M., and Vidal, H. (1997) Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 46, 1319-1327.
-
(1997)
Diabetes
, vol.46
, pp. 1319-1327
-
-
Auboeuf, D.1
Rieusset, J.2
Fajas, L.3
Vallier, P.4
Frering, V.5
Riou, J.P.6
Staels, B.7
Auwerx, J.8
Laville, M.9
Vidal, H.10
-
16
-
-
0027256247
-
Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442a cells
-
16. Sandouk, T., Reda, D., and Hofmann, C. (1993) Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am. J. Physiol. 264, C1600-1608.
-
(1993)
Am. J. Physiol.
, vol.264
-
-
Sandouk, T.1
Reda, D.2
Hofmann, C.3
-
17
-
-
0029745382
-
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: Binding and activation correlate with antidiabetic actions in db/db mice
-
17. Berger, J., Bailey, P., Biswas, C., Cullinan, C. A., Doebber, T. W., Hayes, N. S., Saperstein, R., Smith, R. G., and Leibowitz, M. D. (1996) Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: Binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137, 4189-4195.
-
(1996)
Endocrinology
, vol.137
, pp. 4189-4195
-
-
Berger, J.1
Bailey, P.2
Biswas, C.3
Cullinan, C.A.4
Doebber, T.W.5
Hayes, N.S.6
Saperstein, R.7
Smith, R.G.8
Leibowitz, M.D.9
-
18
-
-
0030033508
-
Effects of troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy
-
18. Iwamoto, Y., Kosaka, K., Kuzuya, T., Akanuma, Y., Shigeta, Y., and Kaneko, T. (1996) Effects of troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy. Diabetes Care 19, 151-156.
-
(1996)
Diabetes Care
, vol.19
, pp. 151-156
-
-
Iwamoto, Y.1
Kosaka, K.2
Kuzuya, T.3
Akanuma, Y.4
Shigeta, Y.5
Kaneko, T.6
-
19
-
-
0031015407
-
Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone
-
19. Antonucci, T., Whitcomb, R., McLain, R., and Lockwood, D. (1997) Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone. Diabetes Care 20, 188-193.
-
(1997)
Diabetes Care
, vol.20
, pp. 188-193
-
-
Antonucci, T.1
Whitcomb, R.2
McLain, R.3
Lockwood, D.4
-
20
-
-
0031589186
-
Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPARγ) gene
-
20. Beamer, B. A., Negri, C., Yen, C-J., Gavrilova, O., Rumberger, J. M., Durcan, M. J., Yarnall, D. P., Hawkins, A. L., Griffin, C. A., Burns, D. K., Roth, J., Reitman, M., and Shuldiner, A. R. (1997) Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPARγ) gene. Biochem. and Biophys. Res. Commun. 233, 756-759.
-
(1997)
Biochem. and Biophys. Res. Commun.
, vol.233
, pp. 756-759
-
-
Beamer, B.A.1
Negri, C.2
Yen, C.-J.3
Gavrilova, O.4
Rumberger, J.M.5
Durcan, M.J.6
Yarnall, D.P.7
Hawkins, A.L.8
Griffin, C.A.9
Burns, D.K.10
Roth, J.11
Reitman, M.12
Shuldiner, A.R.13
-
22
-
-
0030835678
-
The organization, promoter analysis, and expression of the human PPARγ gene
-
22. Fajas, L., Auboeuf, D., Raspe, E., Schoonjas, K., Lefebvre, A-M., Saladin, R., Najib, J., Laville, M., Fruchart, J-C., Deeb, S., Vidal-Puig, A., Flier, J., Briggs, M. R., Staels, B., Vidal, H., and Auwerx, J. (1997) The organization, promoter analysis, and expression of the human PPARγ gene. J. Biol. Chem. 272, 18779-18789.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 18779-18789
-
-
Fajas, L.1
Auboeuf, D.2
Raspe, E.3
Schoonjas, K.4
Lefebvre, A.-M.5
Saladin, R.6
Najib, J.7
Laville, M.8
Fruchart, J.-C.9
Deeb, S.10
Vidal-Puig, A.11
Flier, J.12
Briggs, M.R.13
Staels, B.14
Vidal, H.15
Auwerx, J.16
-
23
-
-
0030877565
-
Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ; differential activity of PPARγ1 and -2 isoforms and influence of insulin
-
23. Werman, A., Hollenberg, A., Solanes, G., Bjorbaek, C., Vidal-Puig, A. J., and Flier, J. S. (1997) Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ; differential activity of PPARγ1 and -2 isoforms and influence of insulin. J. Biol. Chem. 272, 20230-20235.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 20230-20235
-
-
Werman, A.1
Hollenberg, A.2
Solanes, G.3
Bjorbaek, C.4
Vidal-Puig, A.J.5
Flier, J.S.6
-
24
-
-
0028180070
-
M: mPPARγ2: Tissue-specific regulator of an adipocyte enhancer
-
24. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., and Spiegelman, B. M: mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234.
-
Genes Dev.
, vol.8
, pp. 1224-1234
-
-
Tontonoz, P.1
Hu, E.2
Graves, R.A.3
Budavari, A.I.4
Spiegelman, B.5
|